Outlook Therapeutics OTLK
NASDAQ OTLK
$0.48 +0.02 (+4.43%)
At close: Nov 11, 2026 · 4:00 PM EST

Outlook Therapeutics (OTLK) Receivables - Other (2015 - 2016)

Updated

Outlook Therapeutics' Receivables - Other was $43,350 in fiscal Q3 2016 (quarter ended Jun 30, 2016), up 0.4% from the prior quarter.

Analysis

Outlook Therapeutics (OTLK) Receivables - Other (2015 - 2016) Analysis & Trends

At the end of FY2015 (ended Sep 30, 2015), Receivables - Other at Outlook Therapeutics came in at $117,506.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Outlook Therapeutics 62.90 Mn 27.15 Mn -8,265.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2016 43,350.00
Mar 31, 2016 43,187.00
Sep 30, 2015 117,506.00
API Access

Outlook Therapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=OTLK&period=max&api_key=YOUR_API_KEY